BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mancuso A. Management of hepatocellular carcinoma: Enlightening the gray zones. World J Hepatol 2013; 5(6): 302-310 [PMID: 23805354 DOI: 10.4254/wjh.v5.i6.302]
URL: https://www.wjgnet.com/1948-5182/full/v5/i6/302.htm
Number Citing Articles
1
Andrea Mancuso. Evidence-based medicine and Management of Hepatocellular Carcinoma in ThalassemiaBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01542-2
2
Audrey E. Ertel, Shimul A. Shah. Surgical Approaches to Hepatocellular CarcinomaSeminars in Roentgenology 2016; 51(2): 88 doi: 10.1053/j.ro.2016.02.004
3
Andrea Mancuso. Budd-Chiari Syndrome2020; : 245 doi: 10.1007/978-981-32-9232-1_19
4
Bing Han, Chuan Li, Hao Meng, Fernando Gomes Romeiro, Andrea Mancuso, Zhirui Zhou, Giovanni Battista Levi Sandri, Ying Xu, Tao Han, Lei Han, Lichun Shao, Xingshun Qi. Efficacy and safety of external-beam radiation therapy for hepatocellular carcinoma: An overview of current evidence according to the different target populationBioScience Trends 2019; 13(1): 10 doi: 10.5582/bst.2018.01261
5
Bassel Hafez, Bassam Osman, Joelle Chami, Jana Haidar Ahmad, Karim Ataya, Mohamad Jawad Khalife. Management of ruptured hepatocellular carcinoma invading the gastrointestinal tract: A case reportInternational Journal of Surgery Case Reports 2022; 96: 107330 doi: 10.1016/j.ijscr.2022.107330
6
John C. Wood. Use of Magnetic Resonance Imaging to Monitor Iron OverloadHematology/Oncology Clinics of North America 2014; 28(4): 747 doi: 10.1016/j.hoc.2014.04.002
7
Hassan M. Moukhadder, Racha Halawi, Maria Domenica Cappellini, Ali T. Taher. Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive reviewCancer 2017; 123(5): 751 doi: 10.1002/cncr.30462
8
Andrea Mancuso. Timing of transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: An Italian hepatologist’s perspectiveJournal of Translational Internal Medicine 2017; 5(4): 194 doi: 10.1515/jtim-2017-0033
9
Ailinh L. Do, Carrie R. Wong, Long H. Nguyen, Vincent G. Nguyen, Huy Trinh, Mindie H. Nguyen. Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All EtiologiesJournal of Clinical Gastroenterology 2014; 48(7): 644 doi: 10.1097/MCG.0000000000000015
10
Hassan M. Moukhadder, Joseph E. Roumi, Rayan Bou-Fakhredin, Ali T. Taher. Hepatocellular Carcinoma in a β-Thalassemia Intermedia Patient: Yet Another Case in the Expanding EpidemicHemoglobin 2018; 42(1): 58 doi: 10.1080/03630269.2018.1434197
11
Andrea Mancuso. Management of hepatocellular carcinoma in thalassemia and importance of the human factorCancer 2017; 123(6): 1071 doi: 10.1002/cncr.30551
12
Andrea Mancuso, Alberto Maringhini. Management of hepatocellular carcinoma recurrence after liver transplant is far from perfectThe American Journal of Surgery 2018; 216(2): 389 doi: 10.1016/j.amjsurg.2017.04.004
13
Zhiqiang Wu, Wenbo Guo, Song Chen, Wenquan Zhuang. Determinants of pain in advanced HCC patients recieving hepatic artery infusion chemotherapyInvestigational New Drugs 2021; 39(2): 394 doi: 10.1007/s10637-020-01009-x
14
Jin-Min Kim, Seung-Hyun Lee, Woo Young Shin, Keon-Young Lee, Jun Mee Kim, Seung-Ik Ahn. Intrahepatic recurrence of single nodular hepatocellular carcinoma after surgical resection: an analysis by segmental distributionANZ Journal of Surgery 2018; 88(12): E840 doi: 10.1111/ans.14824
15
Antoine Finianos, Charbel Matar, Ali Taher. Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver CarcinogenesisInternational Journal of Molecular Sciences 2018; 19(12): 4070 doi: 10.3390/ijms19124070
16
Ali Mteyrek, Elisabeth Filipski, Catherine Guettier, Alper Okyar, Francis Lévi. Clock gene Per2 as a controller of liver carcinogenesisOncotarget 2016; 7(52): 85832 doi: 10.18632/oncotarget.11037
17
Dejiang Pang, Chengcheng Yang, Chao Li, Yuanfeng Zou, Bin Feng, Lixia Li, Wentao Liu, Qihui Luo, Zhengli Chen, Chao Huang. Polyphyllin II inhibits liver cancer cells proliferation, migration and invasion through down-regulated cofilin activity and AKT/NF-κB pathwayBiology Open 2020;  doi: 10.1242/bio.046854
18
Yan Wang, Jing Hu, Danhua Xiang, Xinyi Peng, Qingjun You, Yong Mao, Dong Hua, Jian Yin. Targeted nanosystem combined with chemo-photothermal therapy for hepatocellular carcinoma treatmentColloids and Surfaces A: Physicochemical and Engineering Aspects 2020; 596: 124711 doi: 10.1016/j.colsurfa.2020.124711
19
Alessandra Mangia, Davide Bellini, Umberto Cillo, Andrea Laghi, Giuseppe Pelle, Vanna Maria Valori, Eugenio Caturelli. Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidenceBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01391-z
20
Javier Tejeda-Maldonado, Ignacio García-Juárez, Jonathan Aguirre-Valadez, Adrián González-Aguirre, Mario Vilatobá-Chapa, Alejandra Armengol-Alonso, Francisco Escobar-Penagos, Aldo Torre, Juan Francisco Sánchez-Ávila, Diego Luis Carrillo-Pérez. Diagnosis and treatment of hepatocellular carcinoma: An updateWorld Journal of Hepatology 2015; 7(3): 362-376 doi: 10.4254/wjh.v7.i3.362
21
Ali Mteyrek, Elisabeth Filipski, Catherine Guettier, Malgorzata Oklejewicz, Gijsbertus T.J. van der Horst, Alper Okyar, Francis Lévi. Critical cholangiocarcinogenesis control by cryptochrome clock genesInternational Journal of Cancer 2017; 140(11): 2473 doi: 10.1002/ijc.30663
22
Kandasamy Ashokachakkaravarthy, Biju Pottakkat. Mitotic quiescence in hepatic cancer stem cells: An incognito modeOncology Reviews 2020; 14(1) doi: 10.4081/oncol.2020.452